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Background: We reported earlier that X-box binding protein1 spliced (XBP1S), a key regulator of the unfolded
protein response (UPR), as a bone morphogenetic protein 2 (BMP2)-inducible transcription factor, positively
regulates endochondral bone formation by activating granulin-epithelin precursor (GEP) chondrogenic growth
factor. Under the stress of misfolded or unfolded proteins in the endoplasmic reticulum (ER), the cells can be
protected by the mammalian UPR. However, the influence of activating transcription factor 6 (ATF6), another
transcriptional arm of UPR, in BMP2-induced chondrocyte differentiation has not yet been elucidated. In the current
study, we investigate and explore the role of ATF6 in endochondral bone formation, focus on associated molecules
of hypertrophic chondrocyte differentiation, as well as the molecular events underlying this process.
Methods: High-cell-density micromass cultures were used to induce ATDC5 and C3H10T1/2 cell differentiation into
chondrocytes. Quantitative real-time PCR, immunoblotting analysis, and immunohistochemistry were performed to
examine (1) the expression of ATF6, ATF6α, collagen II, collagen X, and matrix metalloproteinase-13 (MMP13) and
(2) whether ATF6 stimulates chondrogenesis and whether ATF6 enhances runt-related transcription factor 2
(Runx2)-mediated chondrocyte hypertrophy. Culture of fetal mouse bone explants was to detect whether ATF6
stimulates chondrocyte hypertrophy, mineralization, and endochondral bone growth. Coimmunoprecipitation was
employed to determine whether ATF6 associates with Runx2 in chondrocyte differentiation.
Results: ATF6 is differentially expressed in the course of BMP2-triggered chondrocyte differentiation. Overexpression of
ATF6 accelerates chondrocyte differentiation, and the ex vivo studies reveal that ATF6 is a potent stimulator of
chondrocyte hypertrophy, mineralization, and endochondral bone growth. Knockdown of ATF6 via a siRNA approach
inhibits chondrogenesis. Furthermore, ATF6 associates with Runx2 and enhances Runx2-induced chondrocyte
hypertrophy. And, the stimulation effect of ATF6 is reduced during inhibition of Runx2 via a siRNA approach,
suggesting that the promoting effect is required for Runx2.
Conclusions: Our observations demonstrate that ATF6 positively regulates chondrocyte hypertrophy and
endochondral bone formation through activating Runx2-mediated hypertrophic chondrocyte differentiation.
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Elaborate chondrogenesis is a convoluted biological
process initiated by the growth of chondrocytes in the
primary center of ossification. Besides the interactions
between cells and growth factors, matrix proteins, and
other environmental factors that mediate cellular sig-
naling pathways, transcription of specific genes in a
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(BMP2) is one of the most important cytokines and
plays several important roles in a variety of cellular func-
tions ranging from embryogenesis, cell growth, and dif-
ferentiation to bone development and the repair of bone
fractures [4, 5]. It is known that BMP2 can activate un-
folded protein response (UPR)-signaling molecules, such
as BiP (binding immunoglobulin protein), CHOP (C/EBP
homologous protein), ATF4 (activating transcription
factor 4), and IRE1α (inositol-requiring enzyme-1α). Re-
cently, another BMP2-signaling pathway in osteoblasts,is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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reticulum (ER) stress, was reported by Murakami et al [6].
ER stress activates a set of signaling pathways collect-
ively termed as the unfolded protein response, which
can mitigate the accumulation of misfolded or unfolded
proteins in the endoplasmic reticulum [7–9]. The UPR
is divided into three arms, including the PKR-like ER-
resistant kinase (PERK), activating transcription factor 6
(ATF6), and IRE1α; the three together act to restrict new
protein synthesis and increase the production of chaper-
ones. ATF6 is an endoplasmic reticulum membrane-
bound transcription factor that regulates various cellular
functions [10–14].
We previously reported that BMP2 induces mild ER
stress during chondrocyte differentiation and activates
the IRE1α–XBP1 pathway. And then, X-box binding
protein1 spliced (XBP1S) positively regulates endochon-
dral bone formation by activating granulin-epithelin pre-
cursor (GEP) chondrogenic growth factor [13]. Jang
et al. reported that BMP2 can activate UPR transducers,
such as PERK, OASIS (old astrocyte specifically induced
substance), and ATF6. BMP2 induces osteoblast differ-
entiation through runt-related transcription factor 2
(Runx2)-dependent ATF6 expression, which directly
regulates osteocalcin transcription. We also found that
ATF6 was a positive regulator of ER stress-mediated
apoptosis in chondrocyte differentiation [15]. However,
whether ATF6 can influence the chondrocyte differenti-
ation and endochondral bone growth has not yet been
elucidated; specifically, the molecular mechanism under-
lying these processes remains unexplored. The purpose
of this study was to investigate the role of ATF6 during
the course of chondrogenesis and bone formation. We
particularly focus on associated molecules of hyper-
trophic chondrocyte differentiation. In this study, we
attempted to determine whether ATF6 is essential for
skeletal development by using both in vitro and in vivo
approaches. Our results support a novel role of ATF6




With the approval of the Chongqing Medical University
Institutional Animal Care and Use Committee (permit
number: SYXK 2007-0001, SCXK 2007-0002), all mice
were housed under controlled temperatures in a 12-h
light/dark cycle with easy access to food and water. This
study was carried out in strict accordance with the rec-
ommendations in the Guide for the Care and Use of
Laboratory Animals of the National Science Foundation
of China. The protocol was approved by the Committee
on the Ethics of Animal Experiments of Chongqing
Medical University. All surgeries were performed undersodium pentobarbital anesthesia, and all efforts were
made to minimize suffering.
Plasmids and adenoviruses
The AdEasy adenoviral vector system (Invitrogen, Carlsbad,
CA) was used to construct an adenovirus expressing
ATF6 (Ad-ATF6). Briefly, ATF6 complementary DNA
(cDNA) was inserted into the Xho I and Hind III sites in
pAdTrack-cytomegalovirus (CMV) vector. The predi-
gested recombinant adenovirus DNA was transfected into
human embryonic kidney 293 cells. After collecting the
medium supernatant that contains recombinant adeno-
virus, multiplicity of infection (MOI) for the recombinant
adenovirus was determined according to the standard
protocol. The expression of recombinant virus in infected
ATF6 cells was tested by Western blotting with specific
antibodies.
To generate ATF6 small interfering RNA (siRNA) ex-
pression constructs, siRNA corresponding to the coding
sequence of the ATF6 gene (5′-AGCACCCAAGACT
CAAACA ATTTT-3′) [15] was cloned into a pSES-HUS
vector (an adenoviral shuttle vector expressing siRNA)
according to the manufacturer’s instructions. Briefly,
equimolar amounts of complementary sense and anti-
sense strands were separately mixed, annealed, and
slowly cooled to 10 °C in a 50-μl reaction buffer
(100 mM NaCl and 50 mM HEPES, pH 7.4). The
annealed oligonucleotides were inserted into the SfiI
sites of pSES-HUS vector. All constructs were verified
by nucleic acid sequencing; subsequent analysis was per-
formed using BLAST software (National Institutes of
Health).
Adenovirus Runx2 (Ad-Runx2) and siRunx2 were con-
structed, respectively, using methods described previ-
ously [13, 16].
Cell culture
The micromass culture was performed as described pre-
viously [13, 17]. Briefly, multipotent murine CH10T1/2
cells were trypsinized and resuspended in Dulbecco’s
modified Eagle’s medium (DMEM) with 10 % fetal bo-
vine serum (FBS) at a concentration of 106 cells/ml, and
six drops of 100 μl of cells were placed in a 60-mm tis-
sue culture dish (BD Biosciences), respectively. After 2-h
incubation at 37 °C, 1 ml of DMEM containing 10 %
FBS and BMP2 protein (300 ng/ml) was added. The
medium was replaced approximately every 2–3 days. To
test the effect of overexpression of ATF6 protein on
chondrogenesis, C3H10T1/2 cells were infected with
BMP2, BMP2 + Ad-ATF6 expression adenovirus, and
control green fluorescent protein (GFP) adenovirus be-
fore micromass culture.
Mouse chondrogenic ATDC5 cells were maintained in
a medium consisting of a 1:1 mixture of DMEM and
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containing 5 % FBS (Invitrogen), 10 mg/ml human
transferrin (Roche Applied Science), and 30 nM sodium
selenite (Sigma) at 37 °C in a humidified atmosphere of
5 % CO2 in air. The ATDC5 cells were seeded at a dens-
ity of 3 × 105 cells/well in 6-well cell culture plates
(Corning). The medium was replaced every other day.
For adenovirus (Ad-ATF6 or Ad-GFP) infection and Ad-
ATF6 siRNA, Ad-RFP infection, the same protocol as
used with C3H10T1/2 cells was followed.
Immunohistochemistry
Sections of postcoital day 15.5 and 17.5 embryos, newborn
mice, and day 10 mice were deparaffinized, rehydrated,
and placed in Tris buffer (10 mM Tris-HCl (pH 8.0),
150 mM NaCl). Serum block was applied for 30 min at
room temperature before incubation of the primary anti-
body. Anti-mouse ATF6 (Bio-Legend) was diluted 1:50,
and sections were incubated at room temperature for 2 h.
For detection, biotinylated secondary antibody and horse-
radish peroxidase (HRP)-streptavidin complex (Santa
Cruz Biotechnology, Inc., Santa Cruz, CA) were used.
HRP substrate was used for visualization, and sections
were then counterstained with Mayer’s hematoxylin.
Quantitative real-time PCR
To examine the effects of ATF6 on the chondrocyte dif-
ferentiation, C3H10T1/2 or ATDC5 cells were plated at
a density of 3 × 105 cells/well in 6-well tissue culture
plates. One microgram of Ad-ATF6 or siATF6 was then
infected into these cells, respectively.
After 48 h, total RNAs were isolated using the RNeasy
mini kit (Qiagen, Hilden, Germany) and reverse tran-
scribed into cDNA. Real-time PCR was performed with an
ABI 7400 system using the TaqMan EZ RT-PCR kit ac-
cording to the manufacturer’s protocol. TaqMan primers
and probes were derived from the commercially available
TaqMan assay-on-demand gene expression products. We
select GAPDH as the endogenous control for the real-
time PCR relative quantification analysis. PCR cycling
conditions were as follows: initial incubation step of
2 min at 50 °C, reverse transcription of 60 min at
60 °C and 94 °C for 2 min, followed by 40 cycles of
15 s at 95 °C for denaturation and 2 min at 62 °C for
annealing and extension.
In the case of collagen II, collagen X, and matrix
metalloproteinase-13 (MMP13), real-time PCR was run
using the SYBR Green PCR kit, and the following
primers were used: sense (3′-AACGAGAACGACGAG
GTGGT-5′) and antisense (3′-AAAGGAGGCAGAT
GACAG GTGAC-5′) for collagen II, sense (3′-TAC
CACGTGCATGTGAAAGG-5′) and antisense (3′-GGA
GCCACTAGGAATC CTGAG-5′) for collagen X, and
sense (3′-CAGTTTGCAGAGCGCTACCTG AG-5′) andantisense(3′-GGGTTCCTGATGTGGGTG-5′) for MMP13.
The following pair of oligonucleotides was used as internal
controls: 5′-ACCACAGTCCATGCCATCAC-3′ and 5′-
TCCACCACCCTGTTGCTG TA-3′ for GAPDH.
Immunoblotting analysis
To examine the expression of ATF6 and collagen X pro-
tein in the course of chondrogenesis, total cell extracts pre-
pared from micromass cultures of C3H10T1/2 cells in the
presence of 300 ng/ml recombinant BMP2 protein were
mixed with 5 × sample buffer (312.5 mM Tris-HCl (pH
6.8), 5 % β-mercaptoethanol, 10 % SDS, 0.5 % bromphenol
blue, 50 % glycerol). Proteins (1 μg/μl) were resolved on a
10 % SDS-polyacrylamide gel and electroblotted onto a
nitrocellulose membrane. After blocking in 10 % nonfat
dry milk in Tris buffer, saline Tween 20 (10 mM Tris-HCl
(pH 8.0), 150 mM NaCl, 0.5 % Tween 20), blots were incu-
bated with either mouse monoclonal anti-ATF6 antibody
(diluted 1:500; Bio-Legend) or rabbit polyclonal anti-
collagen X (diluted 1:500; Santa Cruz Biotechnology, Inc.)
for 1 h. After washing, the respective secondary antibody
(HRP-conjugated anti-mouse immunoglobulin or HRP-
conjugated anti-rabbit immunoglobulin (Sigma), both
1:1000 dilution) was added, and bound antibody was
visualized using an enhanced chemiluminescence sys-
tem (Amersham Biosciences).
Culture of fetal mouse bone explants
Fetal mouse metatarsals were dissected from 15-day-old
mouse embryos and cultured in DMEM (Gibco, Carlsbad,
CA, USA) containing 1 % heat-inactivated fetal calf serum
(Invitrogen) and 100 U penicillin-streptomycin per milli-
liter in the absence or presence of various stimuli for
5 days, as indicated in Fig 2.
For alizarin red and Alcian Blue staining (alizarin red
staining for the detection of mineralized bone and
Alcian Blue staining for the detection of cartilage), the
explants were placed in 4 % paraformaldehyde in
phosphate-buffered saline for overnight fixation. Subse-
quently, explants were placed in staining solution
(0.05 % alizarin red, 0.015 % alcian blue, 5 % acetic acid
in 70 % ethanol) for 45–60 min. Digital images of
stained bones were analyzed. For safranin O–fast green
staining (safranin O staining for the detection of cartil-
age and fast green staining for subchondral bone and
extracellular matrix), explants were fixed in 96 % alcohol
and processed for paraffin embedding. Sections were
stained with 0.1 % safranin O (orange stain) to evaluate
cartilage matrices and with 0.03 % fast green to evaluate
morphological features as previously described [13, 18].
Coimmunoprecipitation
Approximately 500 mg of cell extract proteins were pre-
pared from C3H10T1/2 cells treated with BMP2 for
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were incubated with anti-Runx2 (20 mg/ml; Santa Cruz
Biotechnology, Inc.) or control rabbit IgG (25 mg/ml)
antibodies for 1 h, followed by incubation with 30 ml of
protein A-agarose (PerkinElmer Life Sciences) at 4 °C
overnight. After washing five times with immunoprecipi-
tation buffer, bound proteins were released by boiling in
20 ml of 2 × SDS loading buffer for 3 min. Released
proteins were examined by Western blotting with
anti-ATF6 antibody, and the signal was detected using
the ECL chemiluminescent system.
Statistical test
The statistical analysis was performed with SPSS 10.0.1
software for Windows. Data were expressed as mean ±
SD from at least three independent experiments. Data
for multiple variable comparisons were analyzed by one-
way analysis of variance. p values of <0.05 were deemed
statistically significant.
Results
Differential expression of ATF6 in the course of
chondrogenesis
We next studied ATF6 and ATF6a expression profiles
during chondrocyte differentiation using the ATDC5 cell
line, a pluripotent murine stem cell line that is a well-Fig. 1 Expression of ATF6 and ATF6a in the course of chondrogenesis in a
was prepared from micromass cultures of ATDC5 cells in the presence of 3
the mRNA expression of ATF6a, collagen II, collagen X, MMP13, and GAPDH
e Western blotting assay. After incubation of micromass cultures of ATDC5
lysed, and 40-mg protein samples were assayed for ATF6, ATF6a, collagen X
anti-ATF6, anti-collagen X, or anti-tubulin, respectively. The arrow is proteinestablished in vitro cell model. Cells were harvested at
various time points followed by real-time PCR for mea-
surements of ATF6a, collagen II, collagen X, and
MMP13 (Fig. 1a–d). As revealed in Fig. 1a–d, the mRNA
level of ATF6a was relatively low until day 5, when it
had doubled, and thereafter remained at high levels dur-
ing the differential stage, although collagen II declined
after 3 days of BMP2 treatment. Note that indication of
the high level of ATF6a was 2 days earlier than that of
collagen X and MMP13, two specific markers for hyper-
trophic chondrocytes, therefore suggesting that ATF6a
may regulate chondrocyte hypertrophy through collagen
X and MMP13 expression.
Then, we examined the protein expression profiles of
ATF6 and ATF6a during chondrocyte differentiation.
BMP2 induces mild ER stress, and then ATF6, as a 90-
kDa protein (p90ATF6) in previous non-ER stress en-
vironment, is directly converted to a 50-kDa protein
(p50ATF6, ATF6a) in ER-stressed cells. As revealed in
Fig. 1e, ATF6 undergoes proteolysis and splicing after
BMP2 stimulation. ATF6a protein was not detected until
day 5 in BMP2-induced chondrocyte differentiation of
ATDC5 cells. The expression of collagen X was also im-
mune positive at day 7, indicating that ATF6a expression
is prehypertrophic and hypertrophic chondrocyte-specific.
The ER stress-induced ATF6 proteolysis occurs in BMP2micromass culture of ATDC5 cells. a–d Real-time PCR assay. Total RNA
00 ng/ml recombinant BMP2 for various time points, as indicated, and
(serving as an internal control) were examined by real-time PCR.
cells with 300 ng/ml BMP2 for the times indicated, the cells were
, and tubulin (serving as an internal control) by Western blotting with
ATF6, ATF6a, and collagen X, respectively
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was 2 days earlier than that of collagen X.ATF6 expression patterns in the chondrocytes of the
growth plate in vivo
It is reported that ER stress signal molecules were
associated with chondrogenesis [19–21]. In this study,
we sought to determine whether ATF6, an important
transcription factor in ER stress, was also involved
in the chondrocyte differentiation. First, we examined
the temporal and spatial expression pattern of ATF6
during skeletal development using an immunostaining
assay at multiple time points, including embryonic
day(E) E15.5, and E17.5, as well as postnatal deve-
lopmental stages (newborn and 10 days). As revealed
in Fig. 2, ATF6 demonstrated prominent expression
throughout the growth plate chondrocytes at post-
coital days 15.5 (b, g) and 17.5 (c, h), and in the
newborn (d, i) and 10-day mice (e, j), NC (a, f ) is
negative control. These results suggested that the ex-
pression profile of ATF6 is closely linked to the entire
chondrogenic period, including proliferating zone (P)
and hypertrophic zone (H), especially highly expressed
in the hypertrophic chondrocyte stage.Fig. 2 Expression of ATF6 in the growth plate chondrocytes in vivo. ATF6 imm
embryo (E15.5; b, g), postcoital day 17.5 mouse embryo (E17.5; c, h), newborn
stained with anti-ATF6 antibody (brown) and counterstained with hematoxylin
chondrogenic developmental stages in both proliferating and hypertrophic z
NC (a, f) negative control, P proliferating chondrocytes, H hypertrophic chondOverexpressing ATF6 activates chondrogenesis in vitro
and endochondral bone formation ex vivo
High-cell-density micromass cultures can differentiate
specifically to the cartilage lineage at high yields when
exposed to chondroinductive factors such as a well-
documented growth factor BMP2 [1–3]. We next sought
to determine the role of ATF6 and BMP2 (300 ng/ml)
during chondrogenesis in micromass cultures of ATDC5
cells and C3H10T1/2 cells [22, 23]. Briefly, the high-
density culture system was incubated in the absence
(control (CTR)) or presence of Ad-ATF6 or 300 ng/ml
BMP2 (serving as a positive control) for induction of
chondrocyte differentiation. Cells were harvested at vari-
ous time points, 3 or 7 days. Therefore, both ATDC5
and C3H10T1/2 cells have the potential to become
chondrocytes, making them a valuable in vitro correlate
for studying the mechanisms of chondrogenesis. Chon-
drogenesis was monitored by analyzing the expressions
of marker genes specific for chondrocytes. ATDC5 or
C3H10T1/2 cells were treated with BMP2, Ad-ATF6 +
BMP2, and control GFP (Ad-GFP), respectively, and then
RNA was extracted every other day for real-time PCR. As
revealed in Fig. 3, chondrocyte differentiation was moni-
tored by examining the expression of collagen II, collagen
X, and MMP13, three marker genes widely used forunohistochemistry in tibial growth plates of postcoital day 15.5 mouse
(d, i) and day 10 old (e, j). Microphotographs are shown of sections
(blue). Immunostaining reveals positive nuclear staining in the entire
ones, and the scale bars represent 100 μm. The red arrow is protein ATF6.
rocytes, M bone metaphysis
Fig. 3 ATF6 stimulates chondrogenesis in vitro. Comparisons of ATF6 and BMP2 in stimulations of chondrogenesis of ATDC5 cells (a–c) and
C3H10T1/2 cells (d–f). Micromass cultures of ATDC5 and C3H10T1/2 cells were incubated in the absence (CTR, Ad-GFP, serves as a control) or
presence of either 300 ng/ml BMP2, Ad-ATF6 (MOI = 50), or Ad-ATF6 (MOI = 50) + BMP2 for 3 or 7 days, and the mRNA levels of Col II (a, d), Col X
(b, e), and MMP13 (c, f) were determined using real-time PCR. The units are arbitrary, and the normalized values were calibrated against control
(CTR), here given the value of 1. The asterisk indicates significant increase or decrease from control (*p < 0.05, **p < 0.01)
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for BMP2, ATF6 markedly induced the expression of col-
lagen II, collagen X, and MMP13. Besides, in Ad-ATF6 +
BMP2-treated ATDC5 cells, the expressions of collagen II,
collagen X, and MMP13 were increased to 1.7-fold, 1.9-
fold, and 1.9-fold, respectively, compared with those in
BMP2-treated cells (Fig. 3a–c). And, in Ad-ATF6 +
BMP2-treated C3H10T1/2 cells, the expressions of colla-
gen II, collagen X, and MMP13 were increased to 1.6-fold,
2.0-fold, and 2.1-fold, respectively, compared with those in
BMP2-treated cells (Fig. 3d–f ). The clearly enhanced ex-
pressions of three marker genes (collagen II, collagen X,
and MMP13) were observed in Ad-ATF6 + BMP2-treated
cells compared with those in BMP2-treated cells, suggest-
ing that overexpression of ATF6 can enhance BMP2-
induced chondrocyte differentiation.
Thus, ATF6 is a positive mediator for chondrocyte dif-
ferentiation and hypertrophy. The difference was statisti-
cally significant between the Ad-ATF6 + BMP2 group
and BMP2 group (*p < 0.05, **p < 0.01).
The effect of ATF6 on endochondral bone forma-
tion was then studied in an ex vivo model of 15-day-
old fetal mouse metatarsal bones. In a 7-day culture
period of Ad-ATF6 (MOI = 50), these explants underwentall sequential stages of endochondral bone formation.
Firstly, ATF6 expression was detected and enhanced
in metatarsals from 15-day-old mouse embryos in-
fected with Ad-ATF6 (Fig. 4a) compared with CTR;
then, the mRNA levels of Col X (b), MMP13 (c) were
determined using real-time PCR. As shown in Fig. 4b, c,
the mRNA levels of Col X and MMP13 were in-
creased after the 15-day-old mouse embryos were in-
fected with Ad-ATF6, suggesting that ATF6 obviously
stimulated chondrocyte hypertrophy and differenti-
ation. Besides, as revealed in Fig. 5, metatarsals from
15-day-old mouse embryos were cultured in the ab-
sence (CTR) or presence of Ad-ATF6 (MOI = 50) for
7 days; then, stained with safranin O/fast green and
alizarin red/Alcian Blue staining of metatarsals, the
result showed that the length of proliferative zone and
hypertrophic zone of the Ad-ATF6 infection group was
elongated compared with CTR, and the percentage in-
crease of total length and mineralized length of the Ad-
ATF6 infection group was also improved compared with
CTR. It was demonstrated that ATF6 significantly stimu-
lated chondrocyte hypertrophy, mineralization, and bone
length. The difference was statistically significant between
the Ad-ATF6 group and BMP2 group (*p < 0.05).
Fig. 4 Expression of ATF6 in the growth plate chondrocytes in vivo. a Immunohistochemistry of ATF6 in the section of long bone from a 15-day-old
mouse embryo. Metatarsals from 15-day-old mouse embryos were cultured in the absence (Ad-GFP, serves as a control) or presence of Ad-ATF6 (MOI =
50) for 7 days, then processed for paraffin embedding and sections were performed. The section was stained with anti-ATF6 polyclonal antibody (brown)
and counterstained with Mayer’s hematoxylin (blue). Immunostaining for ATF6 demonstrates localization of strongly immunopositive chondrocytes in the
lower proliferative/upper hypertrophic zones of the growth plate. The expression of ATF6 dramatically increased after infected with Ad-ATF6, the scale bars
represent 100 μm. The red arrow is protein ATF6. b, c Metatarsals from 15-day-old mouse embryos were cultured in the absence (Ad-GFP) or presence of
Ad-ATF6 (MOI = 50) for 5 days, and the mRNA levels of Col X (b) and MMP13 (c) were determined using real-time PCR. The normalized values were
calibrated against control (CTR). The asterisk indicates significant increase or decrease from control (*p< 0.05)
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differentiation
Having known that ATF6 can enhance hypertrophic
chondrocyte differentiation, we next determined whether
endogenous ATF6 is required for chondrocyte hyper-
trophy by knocking down ATF6 using the siRNA ap-
proach in ATDC5 cells and C3H10 cells. A real-time
PCR was performed to verify the RNA level of ATF6 in
both cells. As shown in Fig. 6a, e, infection with siATF6Fig. 5 ATF6 stimulates chondrocyte hypertrophy, mineralization, and en
metatarsal bones. Metatarsals from 15-day-old mouse embryos were cu
7 days and stained with safranin O/fast green, shown in low-power (a)
length of the proliferating (P) zone and hypertrophic (H) zone in growth plate
d Alizarin red/Alcian Blue staining of metatarsals. Explants were fixed and pro
metatarsal is presented. e Percentage changes in total (T) and mineralization
calculated as (length at d5-length at d0)/length at d0. *p < 0.05 versus controadenovirus resulted in ~79 and 74 % reduction in ATF6
mRNA in ATDC5 cells and C3H10 cells, respectively.
Micromass cultures of ATDC5 cells or C3H10 cells in-
fected with siATF6 adenovirus or control adenovirus
(CTR) were treated with BMP2 for various time points.
As shown in Fig. 6, knockdown of ATF6 obviously abol-
ished the collagen II (Fig. 6b, f ), collagen X (Fig. 6c, g),
and MMP13 (Fig. 6d, h) induction during chondrocyte
differentiation. These findings clearly indicated thatdochondral bone growth. a, b Safranin O/fast green staining of
ltured in the absence (CTR) or presence of Ad-ATF6 (MOI = 50) for
and high-power (b) microphotographs. c Quantification of the
s of metatarsal bones. *p < 0.05 versus control by paired Student’s t test.
cessed for staining. A representative photograph of an explanted
(M) length of metatarsal bones. Percentage changes in bone length were
l; scale bar = 100 μm. Error bars, SD
Fig. 6 Knockdown of ATF6 using the siRNA approach inhibits chondrocyte hypertrophy, as revealed by collagen II, collagen X, and MMP13 expression.
a, e siRNA against ATF6 mRNA efficiently inhibited expression of endogenous ATF6 in both ATDC5 (a) and C3H10 cells (e). Cells were infected with
either Ad-ATF6 siRNA or control adenovirus (CTR), and total RNA was collected for real-time PCR. Expression of ATF6 was normalized against the
GAPDH endogenous control. The normalized values were then calibrated against the control value, here set as 1. *p < 0.05. b, f Repression of ATF6
clearly abolished BMP2-induced Col II expression in ATDC5 (b) and C3H10 (f) cells. Transcript levels of Col II were detected by real-time PCR analysis of
RNA isolated from micromass cultures of ATDC5 (b) or C3H10 (f) cells infected with siATF6 (MOI = 50) or control adenovirus in the presence of
300 ng/ml BMP2 at various time points, as indicated. *p < 0.05. c, g Repression of ATF6 obviously inhibits BMP2-induced Col X expression in ATDC5 (c)
and C3H10 (g) cells. Transcript levels of Col X were detected by real-time PCR analysis of RNA isolated from micromass cultures of ATDC5 (c) or C3H10
(g) cells infected with siATF6 (MOI = 50) or control adenovirus in the presence of 300 ng/ml of BMP2 at various time points, as indicated. *p < 0.05.
d, h Repression of ATF6 largely abolished BMP2-induced MMP13 expression in ATDC5 (d) and C3H10 (h) cells. Transcript levels of MMP13 were
detected by real-time PCR analysis of RNA isolated from micromass cultures of ATDC5 (d) or C3H10 (h) cells infected with siATF6 (MOI = 50) or control
adenovirus in the presence of 300 ng/ml BMP2 at various time points, as indicated. *p < 0.05. Error bars, SD
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induced chondrocyte differentiation and hypertrophy,
and endogenous ATF6 is required for hypertrophic
chondrocyte differentiation.
ATF6 associates with Runx2 during the course of
chondrocyte differentiation
We next sought to elucidate the molecular mechanism by
which ATF6 mediates chondrocyte hypertrophy by deter-
mining whether ATF6 also associates with Runx2 in
hypertrophic chondrocyte differentiation. To test whether
ATF6 binds to Runx2 in micromass culture of C3H10T1/
2 cells treated with BMP2 for 5 days, a coimmunoprecipi-
tation assay was performed. Briefly, extracts from micro-
mass culture C3H10T1/2 cells treated with BMP2 for
5 days were first incubated with control IgG (negative
control) or anti-Runx2 antibodies, and the immunopreci-
pitated complexes were detected by Western blotting with
anti-ATF6 antibody. An ATF6-specific band was present
in the immunoprecipitated complexes brought down by
anti-Runx2 (Fig. 7a, lane 2) but not by control antibodies,demonstrating that ATF6 specifically associates with
Runx2 in C3H10T1/2 cells treated with BMP2 for 5 days.
Next to examine whether ATF6 binds to Runx2 in,
micromass culture of C3H10T1/2 cells treated with BMP2
for 7 days, and a coimmunoprecipitation assay was per-
formed again. First, extracts from C3H10T1/2 cells treated
with BMP2 for 5 days were incubated with control IgG
(Fig. 7b, lane 3) or anti-Runx2 antibodies (Fig. 7b, lane 2),
and the immunoprecipitated complexes were detected
by Western blotting with anti-ATF6 antibody. The result
showed that ATF6 can bind to Runx2 in C3H10T1/2 cells
treated with BMP2 for 7 days, indicating that ATF6 and
Runx2 form a protein complex in BMP2-induced chon-
drogenesis. Together, these results indicate that ATF6 and
Runx2 can form a protein complex in hypertrophic chon-
drocyte differentiation.
ATF6 activates chondrogenesis and endochondral bone
formation is required for Runx2
All is known that Runx2 is required for hypertrophic chon-
drocyte differentiation and activates collagen X expression,
Fig. 7 ATF6 associates with Runx2 in chondrogenesis and ATF6 enhances Runx2-mediated chondrocyte hypertrophy. a ATF6 binds to Runx2
inhypertrophic chondrocyte differentiation of C3H10T1/2 cells treated with BMP2 5 days. Cells lysates prepared from micromass culture of C3H10T1/2 cells
treated with BMP2 5 days were collected and were incubated with either control IgG (lane 3) or Runx2 antibodies (lane 2), followed by protein A-agarose.
The immunoprecipitated (IP) protein complex and cell extracts (lane 1; serving as a positive control) were examined by Western blotting with anti-ATF6
antibody. The arrow is protein ATF6. b ATF6 binds to Runx2 in hypertrophic chondrocyte differentiation of C3H10T1/2 cells treated with BMP2 7 days. Cell
lysates prepared from micromass culture of C3H10T1/2 cells treated with BMP2 7 days were collected and analyzed, respectively, as described in a. The
arrow is protein ATF6. c ATF6 enhanced RUNX2-dependent Col X expression in C3H10T1/2 cells. Transcript levels of Col X were detected by real-time PCR
analysis of RNA isolated from C3H10T1/2 cells infected with either Ad-GFP (control), Ad-RUNX2 (MOI = 50), or Ad-ATF6 + Ad-RUNX2, as indicated. *p <
0.05. d ATF6 enhanced RUNX2-dependent MMP13 expression in C3H10T1/2 cells. Transcript levels of MMP13 were detected by real-time PCR analysis
of RNA isolated from C3H10T1/2 cells infected with Ad-GFP(control), Ad-RUNX2 (MOI = 50), or Ad-ATF6 + Ad-RUNX2, as indicated. RNA was extracted
as described in a, and MMP13 mRNA was detected by real-time PCR. *p< 0.05. e siRUNX2 decreases BMP2-induced Col X expression stimulated by
ATF6 in C3H10T1/2 cells. Transcript levels of Col X were detected by real-time PCR analysis of RNA isolated from micromass culture of
C3H10T1/2 cells infected with either BMP2, BMP2 + Ad-ATF6(MOI = 50), or BMP2 + Ad-ATF6+ siRUNX2(MOI = 50), as indicated. *p < 0.05,
**p < 0.01. f siRUNX2 decreases BMP2-induced MMP13 expression stimulated by ATF6 in C3H10T1/2 cells. Transcript levels of MMP13 were detected by
real-time PCR analysis of RNA isolated from micromass culture of C3H10T1/2 cells infected with either BMP2, BMP2 + Ad-ATF6, or BMP2 + Ad-ATF6 +
siRUNX2, as indicated. *p < 0.05,**p < 0.01. Error bars, SD
Xiong et al. Journal of Orthopaedic Surgery and Research  (2015) 10:141 Page 9 of 12MMP13, and IHH expression [13, 26]. To determine
whether ATF6 affects Runx2-dependent chondrocyte
hypertrophy, micromass culture of C3H10T1/2 cells were
infected with adenovirus encoding ATF6 (Ad-ATF6),
Runx2 (Ad-Runx2), or a combination, and then RNA was
extracted at day 7 for real-time PCR. As shown in Fig. 7c, d,
markedly enhanced expressions of collagen X and MMP13
in Ad-ATF6 +Ad-Runx2-infected cells were observed com-
pared with those in AdRunx2-infected cells. It was demon-
strated that ATF6 effectively increased the collagen X and
MMP13 expression induced by Runx2.
In addition, we also detected whether ATF6 stimulation
effect is required for Runx2, micromass culture C3H10T1/
2 cells were treated with BMP2, adenovirus encoding
ATF6 (Ad-ATF6), Ad-Runx2 siRNA (si-Runx2), or a com-
bination, and then RNA was extracted at day 7 for real-
time PCR. As shown in Fig. 7e, f, remarkable enhanced
expressions of collagen X and MMP13 in (BMP2 +Ad-
ATF6)-treated cells were observed compared with those in
BMP2-treated cells, suggesting that ATF6 obviously in-
creased the collagen X and MMP13 expression induced byBMP2. However, the expression of collagen X and MMP13
was reduced in (BMP2 +Ad-ATF6 + siRunx2)-infected
cells. The promoting effect of ATF6 is clearly inhibited
after siRunx2 infection. It demonstrated that ATF6 acti-
vates chondrogenesis and endochondral bone formation
and the promoting effect of ATF6 depends on Runx2.
Discussion
The endoplasmic reticulum is a central cellular organelle
responsible for the synthesis, folding, and posttrans-
lational modifications of proteins destined for the
secretory pathway. An overload of protein folding in the
ER disrupts ER homeostasis, causing ER stress [27, 28].
Accumulated evidences indicate a physiological role of
UPR during developmental processes. Furthermore, UPR
leads to the ATF6 cleavage by the proteases in the Golgi
complex. Then, the cleaved N-terminal ATF6 cytoplas-
mic domain is released from the Golgi membrane to the
nucleus to regulate transcription. In mammalian cells,
the UPR plays a fundamental role in maintaining cellular
homeostasis and is therefore at the center of many
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studies have shown that factors influencing cell survival
and differentiation are activated during ER stress [29–31],
but how such changes impact differentiation programs in
chondrocytes is poorly understood. Therefore, to test a link
between the ATF6 branch of the UPR and cartilage devel-
opment, we focused on the role of ATF6 in endochondral
bone growth as well as the molecular mechanism.
ATF6 is a multifunctional protein involved in the con-
trol of cell proliferation and the differentiation of nu-
merous types of cells and tissues including skeletal
muscle myotubes, cardiac myocytes, hepatocyte, and os-
teoblasts [14, 32–36]. The current study sought to eluci-
date the role of ATF6 in regulating the chondrocyte
differentiation, with the special focus on the molecular
mechanism underlying this process. BMP2 induces mild
ER stress, and then ATF6 undergoes proteolysis and
produces ATF6a after BMP2 stimulation. The ATF6 and
ATF6a expression profiles were different in the course of
chondrogenesis in vitro. Both of them demonstrated
prominent expression in the entire growth plate chon-
drocyte population in vivo. Real-time PCR result showed
that not until day 5 did the mRNA level of ATF6 be-
come relatively high, and at day 7, it tripled and there-
after remained at high levels during the late differential
stage. The difference between mRNA and the protein of
ATF6 during chondrogenesis suggests that posttran-
scriptional regulations, such as mRNA splice, translation
and stability, and protein degradation, might also be im-
portant in the control of ATF6 expression during chon-
drocyte differentiation.
It is known that ATF6 is an ER membrane-bound bZIP
transcription factor whose structure and mode of action is
similar to those of OASIS. Under normal conditions, ATF6
interacts with the ER protein chaperone BiP/GRP78 and is
retained in the ER membrane [6, 12, 37]. However, upon
the accumulation of unfolded or misfolded proteins in the
ER lumen, ATF6 is released from BiP and, as previously
discussed, cleaved ATF6 will be transported to the nucleus
[14, 33, 34]. In this study, we found that ATF6 functions as
a positive regulator of chondrocyte differentiation, because
overexpression of ATF6 enhances, whereas knockdown of
ATF6 abolishes BMP2-induced chondrocyte differentiation
and hypertrophy, as assayed by the expression of collagen
II, collagen X, and MMP13, three marker genes for
chondrocyte differentiation. The in vitro and in vivo studies
support the concept that ATF6 is a potent stimulator of
chondrocyte differentiation, mineralization, and endochon-
dral bone growth.
Further, we sought to clarify the molecular mechanism
of how to regulate chondrocyte differentiation by ATF6.
As noted, Runx2 is a transcription factor that belongs to
the Runx family. It is an essential central regulator of
osteoblast differentiation and hypertrophic chondrocyteformation. Runx2 regulates the activity of their target
genes by binding to the respective promoter or enhancer
elements in a sequence-specific manner. A large number
of regulatory proteins bind to the C-terminus of Runx2 to
modify its transcriptional function. Besides, Runx2 can
also bind to multiple recognition sites in the collagen X
promoter and activate collagen X reporter constructs [38,
39]. Growing evidences demonstrate that a variety of
Runx2-binding proteins regulates the activity of Runx2
and plays important roles in skeletogenesis [40–43]. Here,
our data showed that ATF6 associates with Runx2 and en-
hances Runx2-induced hypertrophic chondrocyte differ-
entiation. Firstly, ATF6 and Runx2 can form a protein
complex in chondrocyte differentiation, and then over-
expression of ATF6 can enhance the collagen X and
MMP13 expression and then increases Runx2-dependent
hypertrophic chondrocyte differentiation. In addition, the
promoting effect of ATF6 is clearly reduced when Runx2
is inhibited via siRNA. It is suggested that the stimulation
effect of ATF6 is required for Runx2. The results sug-
gested that ATF6 is a cofactor of Runx2 in regulating
hypertrophic chondrocyte differentiation. On the basis of
our earlier findings [13, 15, 16, 18] and the results of this
study, we conclude that ATF6 could positively regulate
chondrocyte differentiation and endochondral bone for-
mation, and this facilitating effect depends on Runx2.
Summary
In a word, ATF6 positively regulates hypertrophic chon-
drocyte differentiation and endochondral bone forma-
tion through activating Runx2-mediated hypertrophic
chondrocyte differentiation. Collectively, this study identi-
fies that ATF6, as a new regulatory factor in the complex
networks, regulates growth plate chondrocyte differenti-
ation and endochondral bone formation. This study pro-
vides novel insights into the role of ATF6 in regulating
chondrocyte differentiation and endochondral bone for-
mation and sheds light on the molecular mechanism
by which ATF6 positively regulates chondrogenesis, i.e.,
ATF6 increases chondrocyte differentiation and endo-
chondral bone formation through activating Runx2 and
endogenous Runx2 is required for ATF6-stimulated chon-
drocyte hypertrophy, mineralization, and endochondral
bone growth. The elucidation of ATF6’s role and molecu-
lar events involved in chondrocyte differentiation will bet-
ter our understanding of normal cartilage development
and the pathogenesis of cartilage disease.
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